Not recommended
Human studies show no meaningful benefit, potential harm, or the risks outweigh any possible upside. Better alternatives exist.
Strongest in Recency (100). Held back by Sample size (5).
Solid mix of RCTs with some methodological gaps.
Few independent replications; results not yet robust.
Small combined sample; treat as preliminary.
Mixed direction across studies.
Most studies are recent (last 2-3 years).
No quantified outcomes yet. Once we have studies with measurable endpoints, you will see per-outcome magnitude here.
Compare across retailers
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.